Preclinical efficacy and rationale of targeting lysine280‐acetylated tau for Alzheimer’s disease therapy with ADEL‐Y01, humanized monoclonal antibody
ADEL-Y01（一种人源化单克隆抗体）靶向赖氨酸280乙酰化tau蛋白治疗阿尔茨海默病的临床前疗效及理论依据
期刊:Nucleic Acids Research
影响因子:13.1
doi:10.1093/nar/30.1.395
Nagaswamy, Uma; Larios-Sanz, Maia; Hury, James; Collins, Shakaala; Zhang, Zhengdong; Zhao, Qin; Fox, George E; Kim, Min‐Seok; Song, Ha‐Lim; Kim, Na‐Young; Mun, Yeon‐Seon; Kim, Dong‐Hou; Yoon, Seung‐Yong
